Category: COVID-19 Vaccine Update

COVID-19 Vaccine News from varies Finance media, we summarize all COVID-19 Vaccine news into a sitemap summary with link to related Vaccine News for the one who wanted to know updated COVID-19 information in timely manner.

Economists question govt’s failure to plan for COVID-19 vaccine funding

CAPE TOWN - Economists are questioning the government’s lack of foresight and planning in ensuring that there are funds to pay for the COVID-19 vaccines.Government has already come under fire for not engaging early enough with vaccine suppliers or planning the roll-out of its vaccination campaign properly.National Treasury has warned that South Africans may have to “bite the bullet” and possibly pay more taxes to fund the vaccine.READ:...

S.Korea in talks to secure 40 mln doses of Novavax’s COVID-19 vaccine

Article contentSEOUL — South Korea is in talks to purchase 40 million doses of a coronavirus vaccine developed by Novavax, its local manufacturer SK bioscience said on Wednesday.The deal, if agreed, will boost supply of COVID-19 vaccines in the country to 146 million doses, more than enough for its 52 million residents, and comes as it prepares to start mass inoculations in February.SK bioscience, which also manufactures AstraZeneca’s...

Germany’s vaccine rollout is not going to plan, frustrating officials and experts

At Leipzig University Hospital, pharmacy students Anne Brandt (l) and Sarah Schulz prepare six syringes from a vial of Biontech/Pfizer's SARS-CoV-2 corona virus vaccine for the vaccination of medical staff. There are currently more requests for vaccination appointments than can be offered at the moment.picture alliance | picture alliance | Getty ImagesSince Germany kicked off its vaccination drive in late December, along with the rest of the EU,...

19 vaccine shots add to confusion over China’s tests for travelers

Article content continuedIt is possible, but not always, experts say. Most vaccines target the “spike” protein on the virus surface to trigger an immune response that could include IgM antibodies.“We can assume that any COVID-19 vaccine containing the spike protein will induce IgM and therefore a diagnostic assay designed to detect spike specific IgM will not be able to differentiate vaccination from infection,” said Helen Fletcher, a professor...

Federal Officials Warn “Mutant” COVID Strain Spreading In US As Cases Decline: Live Upda …

Summary:University of California system to return to in-person classes in the fallFederal officials warn thatUS COVID deaths top 400KCases decline across US; NY releases latest dataUS nears 400K COVID-linked deathsGlobal cases: 95.7MMUK vaccinates 6% of populationBrazil approves US, Chinese vaccinesIsrael opens vaccinations to people in theirUK considering "all possible measures" as deaths spikeGermany extends lockdown to Feb. 14California deaths down day over dayNY saw second straight daily drop...

China’s vaccine cooperation gains momentum worldwide

A staff member checks the packaging quality of COVID-19 inactivated vaccine products at a packaging plant of the Beijing Biological Products Institute Co., Ltd. in Beijing, capital of China, Dec. 25, 2020. (Xinhua/Zhang Yuwei) - "As an ordinary person and the president of Serbia, I am convinced of the quality of the Chinese vaccine, which will be decided by our competent agency," Serbian President Aleksandar Vucic said. -...

How Moderna is working with Dell’s Boomi to become more efficient as races to distribute its C …

The biotech company Moderna works with Dell's Boomi to help it work more effectively, including as it rolls out its coronavirus vaccine. Moderna uses Boomi to connect data in its drug design software with data from SAP and Workday to help it analyze information and estimate costs.  Boomi has also helped Moderna speed up tasks like onboarding, allowing Moderna to focus on its medical research and vaccine distribution....

Elderly begin to drop out of Novavax vaccine trial to get Pfizer and Moderna shots

The subjects wanted to get out of the clinical trial Luft is helping oversee of an experimental vaccine made by another company, Novavax.They wanted to be “unblinded'' and find out if they had received a placebo in the Novavax study, and, if so, try to get the Pfizer and Moderna vaccines, which have already been proved to be about 95 percent effective at preventing coronavirus infections.“The number who...

Teachers are next in line for the Covid vaccine, paving the way for schools to reopen

In his first days in office, President-elect Joe Biden plans to sign an executive order to reopen schools.However, it's not just a matter of federal funding. Vaccinating teachers remains one of the biggest hurdles to returning kids to classrooms.As Covid-19 cases spike across the country, the Centers for Disease Control and Prevention have prioritized teachers and school staff as "essential workers," making them next in line to get the...

Biden’s test: How to lead US out of virus ‘dark winter’

WASHINGTON (AP) — President-elect Joe Biden predicted he would take office amid a “dark winter,” and the outlook is only getting bleaker.No matter his first acts in the White House, the raging coronavirus pandemic could take another 100,000 American lives in his first month as president after crossing the grim marker of 400,000 deaths this week. He inherits a country weary from 10 months of lockdowns and business...

Why Gritstone Oncology Is Bolting Higher Today

What happened Shares of the clinical-stage biotech Gritstone Oncology (NASDAQ:GRTS) rose by as much as 44% in pre-market trading Tuesday morning. The drugmaker's stock is heating up today in response to an agreement with the National Institute of Allergy and Infectious Diseases (NIAID) to initiate a phase 1 trial of its second-generation SARS-CoV-2 vaccine candidate. The NIAID is reportedly covering the cost of the vaccine's early-stage trial through...

Moderna CEO’s 9 Words That Could Mean Billions for the Biotech

Moderna (NASDAQ:MRNA) generated revenue of roughly $60 million in 2019. The company will post total revenue measured in the hundreds of millions of dollars for 2020. But the big bucks begin rolling in this year. Well over 600 million doses of Moderna's COVID-19 vaccine mRNA-1273 will be sold in 2021. Based on its current supply agreements, the company should make around $11.7 billion.  There's been considerable uncertainty, though,...
Close
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages

Site Language


Categories

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close